Osaic Holdings’s Verve Therapeutics VERV Stock Holding History

Osaic Holdings’s Portfolio VERV Stock Details VERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5	Closed	-$25	–	7560
2024 Q2	$25	Hold	5	–	–	﹤0.01%	7332
2024 Q1	$1.95K	Buy	+5	New	+$66	﹤0.01%	6481

Other funds holding VERV

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings's VERV Position: Q4 2025 in Review

Osaic Holdings sold out of Verve Therapeutics (VERV) in Q4 2025, closing a stake of 3,344 shares — an estimated $37.6K sold.

Osaic Holdings first reported a position in VERV in Q4 2021 and held it in 15 quarters. The position peaked at $78K in Q3 2022. 1 fund tracked by Wall St. Rank holds VERV as of Q4 2025.

Osaic Holdings reported no remaining Verve Therapeutics position as of Q4 2025 after selling out during the quarter.
Osaic Holdings sold 3,344 Verve Therapeutics shares in Q4 2025, an estimated $37.6K.
Osaic Holdings first reported a position in Verve Therapeutics in Q4 2021 and held it in 15 quarters.
Osaic Holdings's Verve Therapeutics position peaked at $78K in Q3 2022.
1 fund tracked by Wall St. Rank held Verve Therapeutics as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.